169 related articles for article (PubMed ID: 2349682)
21. Clinical correlations of cyclosporine HPLC and FPIA levels in renal transplant recipients.
Sridhar N; Schroeder TJ; Pesce AJ; First MR
Transplant Proc; 1990 Jun; 22(3):1257-9. PubMed ID: 2190387
[No Abstract] [Full Text] [Related]
22. Monitoring of cyclosporine by serial posttransplant pharmacokinetic studies in renal transplant patients.
Awni WM; Heim-Duthoy K; Kasiske BL
Transplant Proc; 1990 Jun; 22(3):1343-4. PubMed ID: 2349693
[No Abstract] [Full Text] [Related]
23. Should cyclosporine be continued indefinitely?
Stiller CR; Opelz G
Transplant Proc; 1991 Feb; 23(1 Pt 1):36-40. PubMed ID: 1990552
[No Abstract] [Full Text] [Related]
24. Specific and nonspecific monoclonal 125I-Incstar assays.
Wong PY; Ma J
Transplant Proc; 1990 Jun; 22(3):1166-70. PubMed ID: 2349680
[No Abstract] [Full Text] [Related]
25. Combination therapy of cyclosporine and azathioprine in living-related kidney transplant recipients compared with patients converted totally from cyclosporine to azathioprine.
Oka T; Omori Y; Aikawa I; Yasumura T; Yoshimura N; Nakai I
Transplant Proc; 1988 Jun; 20(3 Suppl 3):143-6. PubMed ID: 3291229
[No Abstract] [Full Text] [Related]
26. Cyclosporine monitoring in liver allograft recipients: two distinct patterns of blood level derangement associated with nephrotoxicity.
Wonigeit K; Kohlhaw K; Winkler M; Schaefer O; Pichlmayr R
Transplant Proc; 1990 Jun; 22(3):1305-11. PubMed ID: 2112282
[TBL] [Abstract][Full Text] [Related]
27. Failure of 125I-tracer selective monoclonal antibody levels on a whole blood matrix to predict rejection or nephrotoxic episodes in renal transplant patients under anti-lymphocyte globulin and prednisone therapy.
Stiller C; Keown P
Transplant Proc; 1990 Jun; 22(3):1253-4. PubMed ID: 2349687
[No Abstract] [Full Text] [Related]
28. [Spontaneous kidney transplant rupture--effect of immunosuppressive therapy on incidence of rupture].
Oesterwitz H; Strobelt V; May G; Horlbeck R
Z Urol Nephrol; 1990 Apr; 83(4):157-63. PubMed ID: 2378176
[TBL] [Abstract][Full Text] [Related]
29. Comment on cyclosporine assay techniques: an attempt for recommendations.
Rosenthaler J; Keller HP
Transplant Proc; 1990 Jun; 22(3):1160-5. PubMed ID: 2349679
[No Abstract] [Full Text] [Related]
30. Kinetics of oral ciclosporin in the perioperative period after heart transplantation.
Konertz W; Leimenstoll G; Weyand M; Friedl A; Bernhard A
Bibl Cardiol; 1988; (43):42-5. PubMed ID: 3067722
[No Abstract] [Full Text] [Related]
31. Consensus document: Hawk's Cay meeting on therapeutic drug monitoring of cyclosporine.
Transplant Proc; 1990 Jun; 22(3):1357-61. PubMed ID: 2190399
[No Abstract] [Full Text] [Related]
32. Intravenous cyclosporine for heart transplantation.
Bolman RM; Cance CG
Transplant Proc; 1989 Feb; 21(1 Pt 3):2488. PubMed ID: 2650312
[No Abstract] [Full Text] [Related]
33. Cyclosporine--high-dose steroid interaction in renal transplant recipients: assessment by HPLC.
Ptachcinski RJ; Venkataramanan R; Burckart GJ; Hakala TR; Rosenthal JT; Carpenter BJ; Taylor RJ
Transplant Proc; 1987 Feb; 19(1 Pt 2):1728-9. PubMed ID: 3274417
[No Abstract] [Full Text] [Related]
34. Cyclosporine blood concentrations in the management of renal transplant recipients.
Rogerson ME; Marsden JT; Reid KE; Bewick M; Holt DW
Transplantation; 1986 Feb; 41(2):276-8. PubMed ID: 3511588
[No Abstract] [Full Text] [Related]
35. Optimization by timing of oral cyclosporine to prevent acute kidney allograft rejection in dogs.
Cavallini M; Halberg F; Sutherland DE; Cornélissen G; Heil J; Najarian JS
Transplantation; 1986 May; 41(5):654-7. PubMed ID: 3518168
[No Abstract] [Full Text] [Related]
36. Tailoring cyclosporine according to kinetic profiles: does it allow a low-dose therapeutic schedule?
Segoloni GP; Triolo G; Squiccimarro G; Colla L; Turello E; Aimo G; Pecchio F; Vercellone A
Transplant Proc; 1987 Feb; 19(1 Pt 2):1726-7. PubMed ID: 3274416
[No Abstract] [Full Text] [Related]
37. First month cyclosporine A sparing in renal transplantation.
Segoloni GP; Messina M; Colla L; Piccoli GB; Triolo G; Vercellone A
Transplant Proc; 1988 Jun; 20(3 Suppl 3):233-8. PubMed ID: 3291249
[No Abstract] [Full Text] [Related]
38. Long-term effects of cyclosporine in cardiac transplantation.
Miller LW; Pennington DG; McBride LR
Transplant Proc; 1990 Jun; 22(3 Suppl 1):15-20. PubMed ID: 2349734
[No Abstract] [Full Text] [Related]
39. Cyclosporine approved for kidney, liver, and heart transplants.
FDA Drug Bull; 1984 Apr; 14(1):6-7. PubMed ID: 6376250
[No Abstract] [Full Text] [Related]
40. Effect of discontinuing or restricting cyclosporine on late renal allograft rejection and function.
Woodle ES; Heffron TG; Stuart JK; Thistlethwaite JR; Stuart FP
Transplant Proc; 1989 Feb; 21(1 Pt 2):1641-2. PubMed ID: 2652536
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
